Main Article Content
Abstract
ABSTRACT
Introduction. Rheumatic heart disease remains a leading cause of preventable cardiovascular morbidity in sub-Saharan Africa, where delayed access to specialized care significantly compromises clinical outcomes. Despite the theoretical efficacy of primary prevention, diagnosis often occurs only at the stage of irreversible complications. This study aimed to evaluate the diagnostic characteristics, therapeutic modalities, and prognostic factors of rheumatic valve disease among children and young adults followed in three referral hospitals in Yaoundé. Methods. We conducted an analytical cross-sectional study with retro-prospective data collection over five years. The analysis included all patients with rheumatic valve disease confirmed by Doppler echocardiography in the cardiology departments of the General Hospital, the Central Hospital, and the Chantal Biya Foundation. Results. Of the 106 patients included (median age 10-15 years; 64.2% female), 72% reported a history of untreated sore throats. Mitral regurgitation (82.1%) and aortic insufficiency (42.9%) were the predominant lesions, accounting for the vast majority of the pathological spectrum. At diagnosis, 67% of patients already presented with left heart failure. Although surgery was indicated for 57.5% of subjects, only 23% underwent the procedure after a median delay of 24 months. Mortality stood at 6.3%. Left heart failure (aOR 18.5; 95% CI [1.1–306.1]) and dilation of the left chambers (aOR 21.5; 95% CI [1.4–334.5]) emerged as the primary determinants of a poor prognosis. Conclusion. The diagnosis of rheumatic valve disease in Cameroon occurs at stages of advanced decompensation, exacerbated by limited and delayed access to cardiac surgery. Generalizing the systematic treatment of pharyngitis and implementing early echocardiographic screening are imperative to reduce mortality associated with this disease of poverty.
RÉSUMÉ
Introduction. Rheumatic heart disease remains a leading cause of preventable cardiovascular morbidity in sub-Saharan Africa, where delayed access to specialized care significantly compromises clinical outcomes. Despite the theoretical efficacy of primary prevention, diagnosis often occurs only at the stage of irreversible complications. This study aimed to evaluate the diagnostic characteristics, therapeutic modalities, and prognostic factors of rheumatic valve disease among children and young adults followed in three referral hospitals in Yaoundé. Methods. We conducted an analytical cross-sectional study with retro-prospective data collection over five years. The analysis included all patients with rheumatic valve disease confirmed by Doppler echocardiography in the cardiology departments of the General Hospital, the Central Hospital, and the Chantal Biya Foundation. Results. Of the 106 patients included (median age 10-15 years; 64.2% female), 72% reported a history of untreated sore throats. Mitral regurgitation (82.1%) and aortic insufficiency (42.9%) were the predominant lesions, accounting for the vast majority of the pathological spectrum. At diagnosis, 67% of patients already presented with left heart failure. Although surgery was indicated for 57.5% of subjects, only 23% underwent the procedure after a median delay of 24 months. Mortality stood at 6.3%. Left heart failure (aOR 18.5; 95% CI [1.1–306.1]) and dilation of the left chambers (aOR 21.5; 95% CI [1.4–334.5]) emerged as the primary determinants of a poor prognosis. Conclusion. The diagnosis of rheumatic valve disease in Cameroon occurs at stages of advanced decompensation, exacerbated by limited and delayed access to cardiac surgery. Generalizing the systematic treatment of pharyngitis and implementing early echocardiographic screening are imperative to reduce mortality associated with this disease of poverty.
Keywords
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- 1. Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, et al. The Cardiovasc Dis. 2016; 109:321–329.
- 2. OMS. Rhumatisme articulaire aigu et cardiopathies rhumatismales. OMS; 2018.
- 3. Barry I, Balde El Hadj Y, Koivogui K. valvulopathierhumatismale. Am J of Card and Cardiovas Disc. 2019; 2(2): 01-06.
- 4. Nkoke C, Luchuo EB, Jingi AM, Makoge C, Hamadou B, Dzudie A. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting. Nascimento BR, éditeur. PLoS ONE. 2018;13(9):1-9.
- 5. Bâ H, Sangaré I, Camara Y, Coulibaly S, Sidibé N, Konaté M, et al. Valvulopathies Rhumatismales de l’Adulte au CHU Gabriel Touré : à Propos de 314 Cas. Health Sci. Dis. 2022;23: 34-37.
- 6. Seudjo K. Prévalence, aspects cliniques et évolutifs des valvulopathies post rhumatismales dans deux hôpitaux de la ville de Douala. [Thèse]. Bagangté: Université des montagnes; 2019.97p.
- 7. Jaiteh LES, Drammeh L, Anderson ST, Mendy J, Ceesay S, D’Alessandro U, Carapetis J, Mirabel M, Erhart A. Rheumatic heart disease in The Gambia: clinical and valvular
- 8. Kinda G. Les cardiopathies rhumatismales en milieu pédiatrique à Ouagadougou. Revue Africaine et Malgache de Recherche Scientifique/Sciences de la Santé. 2018; 1(1):17-21.
- 9. Tantchou Tchoumi JC, Butera G. Rheumatic valvulopathies occurence, pattern and follow-up in rural area: the experience of the Shisong Hospital, Cameroon. Bull Soc Pathol Exot. 2009; 102(3):155‑158.
References
1. Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, et al. The Cardiovasc Dis. 2016; 109:321–329.
2. OMS. Rhumatisme articulaire aigu et cardiopathies rhumatismales. OMS; 2018.
3. Barry I, Balde El Hadj Y, Koivogui K. valvulopathierhumatismale. Am J of Card and Cardiovas Disc. 2019; 2(2): 01-06.
4. Nkoke C, Luchuo EB, Jingi AM, Makoge C, Hamadou B, Dzudie A. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting. Nascimento BR, éditeur. PLoS ONE. 2018;13(9):1-9.
5. Bâ H, Sangaré I, Camara Y, Coulibaly S, Sidibé N, Konaté M, et al. Valvulopathies Rhumatismales de l’Adulte au CHU Gabriel Touré : à Propos de 314 Cas. Health Sci. Dis. 2022;23: 34-37.
6. Seudjo K. Prévalence, aspects cliniques et évolutifs des valvulopathies post rhumatismales dans deux hôpitaux de la ville de Douala. [Thèse]. Bagangté: Université des montagnes; 2019.97p.
7. Jaiteh LES, Drammeh L, Anderson ST, Mendy J, Ceesay S, D’Alessandro U, Carapetis J, Mirabel M, Erhart A. Rheumatic heart disease in The Gambia: clinical and valvular
8. Kinda G. Les cardiopathies rhumatismales en milieu pédiatrique à Ouagadougou. Revue Africaine et Malgache de Recherche Scientifique/Sciences de la Santé. 2018; 1(1):17-21.
9. Tantchou Tchoumi JC, Butera G. Rheumatic valvulopathies occurence, pattern and follow-up in rural area: the experience of the Shisong Hospital, Cameroon. Bull Soc Pathol Exot. 2009; 102(3):155‑158.
